Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70010-185

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70010-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150-mg-blister (150 mg Blister)

Multiple identical labels for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 150 mg strength, for oral use. Labels include the proprietary and generic names, dose strength, Rx only status, manufacturer Granules Pharmaceuticals Inc., and a barcode for each label. NDC 70010-186-63 is visible on each.*

FDA Label Image

150mg-carton-label (150 mg Carton Label)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Granules Pharmaceuticals Inc. The label indicates 80 (8 x 10) unit-dose capsules. It includes storage instructions, manufacturer details (Granules India Limited), and a prompt for pharmacists to dispense the Medication Guide separately to each patient. The National Drug Code (NDC) 70010-186-63 appears twice on the label.*

FDA Label Image

150-mg-container-label (150 mg Container Label 500)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg. The label indicates the product is supplied in a package of 500 capsules, is prescription only, and is manufactured by Granules India Limited for Granules Pharmaceuticals Inc. Storage instructions and a URL for medication guides are also shown.*

FDA Label Image

37.5-mg-blister (37 5 mg Blister)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 37.5 mg strength. The label includes the NDC number 70010-184-63 and indicates the product is for prescription use only (Rx only). Manufactured for Granules Pharmaceuticals Inc., the label displays barcodes and placeholders for lot number and expiration date.*

FDA Label Image

37.5-mg-carton-label (37 5 mg Carton Label)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg by Granules Pharmaceuticals Inc. The label indicates an 80 count supply (8 x 10 unit-dose capsules) and includes storage instructions, manufacturer and distributor information, and a medication guide URL. The label is primarily white with blue dosage highlighting and a circular logo with red and blue elements.*

FDA Label Image

37.5-mg-container-label (37 5 mg Container Label)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg, oral dosage form. The label states a package size of 500 capsules. It includes storage instructions, directs dispensing the Medication Guide to patients, and indicates manufacturer Granules India Limited and labeler Granules Pharmaceuticals Inc. Barcodes and NDC 70010-184-05 are visible.*

FDA Label Image

37.5-mg-blister (75 mg Blister)

Label sheet featuring multiple individual labels for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 75 mg strength. Each label includes the NDC code 70010-185-63, the statement 'Rx only', manufacturer information for Granules Pharmaceuticals Inc., a barcode, and placeholders for LOT number and expiration date.*

FDA Label Image

75mg-carton-label (75 mg Carton Label)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, manufactured by Granules India Limited for Granules Pharmaceuticals Inc. The label indicates 80 unit-dose capsules (8 x 10) and notes the requirement for pharmacists to dispense the Medication Guide separately. Storage instructions and manufacturer details are also visible.*

FDA Label Image

75mg-container-label (75 mg Container Label)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg. This oral capsule packaging contains 500 capsules and is manufactured for Granules Pharmaceuticals Inc. The label includes storage instructions, dosage reference, a barcode, and a pharmacist dispensing note. It is marked Rx only and shows the NDC 70010-185-05.*

FDA Label Image

Figure-1 (Figure 1)

A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, ODV) of venlafaxine in various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphisms, age above 60 years, and gender differences (females/males). The x-axis represents change relative to the reference value.*

FDA Label Image

Figure-2 (Figure 2)

A scientific plot showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of venlafaxine and its metabolite ODV relative to various interacting drugs. The x-axis measures change relative to the reference value, with data points for multiple interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Figure-3 (Figure 3)

A scatter plot showing fold changes and 90% confidence intervals for various pharmacokinetic parameters (Cmax and AUC) of different analytes affected by interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents the change relative to a reference value, ranging approximately from 0 to 3.*

FDA Label Image

Structure (Structure)

Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement of the active ingredient venlafaxine hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.